As reported by the Telegraph, scientists at the UK’s largest pharmaceutical company, GlaxoSmithKline (GSK) are to focus their research and development to investigate how traditional Chinese medicine can be used in modern drugs.
Speaking of the news, Moncef Slaoui, GSK’s chairman of Research and Development stated,
“Within our discovery organisation in China we have created a DPU that will marry traditional Chinese medicine with modern drug discovery and clinical efficacy. With modern technology we have the potential to yield new molecular entities with significant efficacy.”
To complete the work, GSK will be opening a new Discovery Performance Unit which will be based in China, a booming pharmaceutical market which is set to grow to more that £63.5bn by 2015.